Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

David Schiff, Kurt A. Jaeckle, S. Keith Anderson, Evanthia Galanis, Caterina Giannini, Jan C. Buckner, Phillip Stella, Patrick J. Flynn, Bradley J. Erickson, John F. Schwerkoske, Vesna Kaluza, Erin Twohy, Janet Dancey, John Wright, Jann N. Sarkaria

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572'. Together they form a unique fingerprint.

Medicine & Life Sciences